CRL Annual D&A
$314.12 M
+$10.25 M+3.37%
30 December 2023
Summary:
As of January 21, 2025, CRL annual depreciation & amortization is $314.12 million, with the most recent change of +$10.25 million (+3.37%) on December 30, 2023. During the last 3 years, it has risen by +$79.20 million (+33.71%). CRL annual D&A is now at all-time high.CRL Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Quarterly D&A
$88.20 M
+$2.12 M+2.46%
28 September 2024
Summary:
As of January 21, 2025, CRL quarterly depreciation & amortization is $88.20 million, with the most recent change of +$2.12 million (+2.46%) on September 28, 2024. Over the past year, it has increased by +$7.68 million (+9.54%). CRL quarterly D&A is now at all-time high.CRL Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL TTM D&A
$340.15 M
+$9.33 M+2.82%
28 September 2024
Summary:
As of January 21, 2025, CRL TTM depreciation & amortization is $340.15 million, with the most recent change of +$9.33 million (+2.82%) on September 28, 2024. Over the past year, it has increased by +$26.03 million (+8.29%). CRL TTM D&A is now at all-time high.CRL TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.4% | +9.5% | +8.3% |
| 3 y3 years | +33.7% | +9.5% | +8.3% |
| 5 y5 years | +94.2% | +9.5% | +8.3% |
CRL Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +18.3% | at high | +31.2% | at high | +28.1% |
| 5 y | 5-year | at high | +58.6% | at high | +70.2% | at high | +71.7% |
| alltime | all time | at high | +2783.2% | at high | +4882.9% | at high | +4371.0% |
Charles River Laboratories International Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $88.20 M(+2.5%) | $340.15 M(+2.8%) |
| June 2024 | - | $86.08 M(+0.8%) | $330.82 M(+2.6%) |
| Mar 2024 | - | $85.36 M(+6.0%) | $322.41 M(+2.6%) |
| Dec 2023 | $314.12 M(+3.4%) | $80.51 M(+2.1%) | $314.12 M(+1.0%) |
| Sept 2023 | - | $78.87 M(+1.5%) | $311.15 M(+1.4%) |
| June 2023 | - | $77.67 M(+0.8%) | $306.89 M(+0.4%) |
| Mar 2023 | - | $77.07 M(-0.6%) | $305.64 M(+0.6%) |
| Dec 2022 | $303.87 M(+14.4%) | $77.55 M(+3.9%) | $303.87 M(+3.5%) |
| Sept 2022 | - | $74.61 M(-2.4%) | $293.57 M(+2.1%) |
| June 2022 | - | $76.42 M(+1.5%) | $287.65 M(+3.0%) |
| Mar 2022 | - | $75.30 M(+12.0%) | $279.33 M(+5.2%) |
| Dec 2021 | $265.54 M(+13.0%) | $67.24 M(-2.1%) | $265.54 M(+2.5%) |
| Sept 2021 | - | $68.69 M(+0.9%) | $259.18 M(+3.6%) |
| June 2021 | - | $68.11 M(+10.7%) | $250.07 M(+4.6%) |
| Mar 2021 | - | $61.51 M(+1.0%) | $239.17 M(+1.8%) |
| Dec 2020 | $234.92 M(+18.6%) | $60.88 M(+2.2%) | $234.92 M(+4.0%) |
| Sept 2020 | - | $59.58 M(+4.1%) | $225.88 M(+3.6%) |
| June 2020 | - | $57.21 M(-0.1%) | $218.06 M(+3.8%) |
| Mar 2020 | - | $57.26 M(+10.5%) | $210.00 M(+6.0%) |
| Dec 2019 | $198.09 M(+22.4%) | $51.83 M(+0.1%) | $198.09 M(+5.5%) |
| Sept 2019 | - | $51.76 M(+5.3%) | $187.84 M(+4.5%) |
| June 2019 | - | $49.15 M(+8.4%) | $179.68 M(+3.3%) |
| Mar 2019 | - | $45.36 M(+9.1%) | $173.93 M(+7.5%) |
| Dec 2018 | $161.78 M(+23.3%) | $41.58 M(-4.6%) | $161.78 M(+5.3%) |
| Sept 2018 | - | $43.59 M(+0.5%) | $153.68 M(+7.1%) |
| June 2018 | - | $43.40 M(+30.7%) | $143.56 M(+8.8%) |
| Mar 2018 | - | $33.21 M(-0.8%) | $131.96 M(+0.6%) |
| Dec 2017 | $131.16 M(+3.6%) | $33.48 M(+0.1%) | $131.16 M(-1.5%) |
| Sept 2017 | - | $33.47 M(+5.2%) | $133.22 M(-0.5%) |
| June 2017 | - | $31.80 M(-1.9%) | $133.86 M(-0.4%) |
| Mar 2017 | - | $32.41 M(-8.8%) | $134.41 M(+6.1%) |
| Dec 2016 | $126.66 M(+33.5%) | $35.54 M(+4.2%) | $126.66 M(+8.6%) |
| Sept 2016 | - | $34.11 M(+5.4%) | $116.67 M(+9.7%) |
| June 2016 | - | $32.35 M(+31.2%) | $106.37 M(+9.5%) |
| Mar 2016 | - | $24.66 M(-3.5%) | $97.17 M(+2.4%) |
| Dec 2015 | $94.88 M(-1.6%) | $25.55 M(+7.3%) | $94.88 M(-0.5%) |
| Sept 2015 | - | $23.81 M(+2.9%) | $95.34 M(-2.3%) |
| June 2015 | - | $23.15 M(+3.5%) | $97.61 M(-1.2%) |
| Mar 2015 | - | $22.37 M(-14.0%) | $98.76 M(+2.4%) |
| Dec 2014 | $96.44 M(-0.2%) | $26.01 M(-0.3%) | $96.44 M(-3.3%) |
| Sept 2014 | - | $26.08 M(+7.3%) | $99.73 M(-0.8%) |
| June 2014 | - | $24.30 M(+21.2%) | $100.57 M(+4.0%) |
| Mar 2014 | - | $20.05 M(-31.6%) | $96.68 M(+0.0%) |
| Dec 2013 | $96.64 M(+18.9%) | $29.30 M(+8.9%) | $96.64 M(+9.8%) |
| Sept 2013 | - | $26.92 M(+31.9%) | $87.99 M(+7.8%) |
| June 2013 | - | $20.41 M(+2.0%) | $81.63 M(+0.4%) |
| Mar 2013 | - | $20.01 M(-3.1%) | $81.28 M(+0.0%) |
| Dec 2012 | $81.28 M | $20.66 M(+0.5%) | $81.28 M(-0.4%) |
| Sept 2012 | - | $20.55 M(+2.4%) | $81.60 M(-0.8%) |
| June 2012 | - | $20.07 M(+0.3%) | $82.22 M(-2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $20.00 M(-4.7%) | $83.97 M(-1.5%) |
| Dec 2011 | $85.23 M(-9.0%) | $20.98 M(-0.9%) | $85.23 M(-3.0%) |
| Sept 2011 | - | $21.17 M(-3.0%) | $87.91 M(-2.6%) |
| June 2011 | - | $21.82 M(+2.6%) | $90.22 M(-1.2%) |
| Mar 2011 | - | $21.27 M(-10.1%) | $91.33 M(-2.5%) |
| Dec 2010 | $93.65 M(+4.1%) | $23.66 M(+0.7%) | $93.65 M(+3.8%) |
| Sept 2010 | - | $23.48 M(+2.4%) | $90.24 M(-1.5%) |
| June 2010 | - | $22.93 M(-2.8%) | $91.60 M(+0.0%) |
| Mar 2010 | - | $23.58 M(+16.4%) | $91.57 M(+1.8%) |
| Dec 2009 | $89.96 M(-1.3%) | $20.25 M(-18.5%) | $89.96 M(-2.8%) |
| Sept 2009 | - | $24.84 M(+8.5%) | $92.53 M(+2.1%) |
| June 2009 | - | $22.90 M(+4.2%) | $90.67 M(-0.1%) |
| Mar 2009 | - | $21.97 M(-3.8%) | $90.81 M(-0.4%) |
| Dec 2008 | $91.18 M(+5.6%) | $22.83 M(-0.6%) | $91.18 M(+1.7%) |
| Sept 2008 | - | $22.97 M(-0.3%) | $89.67 M(+0.4%) |
| June 2008 | - | $23.04 M(+3.1%) | $89.28 M(+1.3%) |
| Mar 2008 | - | $22.35 M(+4.9%) | $88.11 M(+2.0%) |
| Dec 2007 | $86.38 M(+1.5%) | $21.31 M(-5.6%) | $86.38 M(-1.4%) |
| Sept 2007 | - | $22.59 M(+3.3%) | $87.60 M(+1.3%) |
| June 2007 | - | $21.87 M(+6.1%) | $86.50 M(+0.9%) |
| Mar 2007 | - | $20.61 M(-8.5%) | $85.71 M(+0.7%) |
| Dec 2006 | $85.13 M(-5.5%) | $22.54 M(+4.9%) | $85.13 M(+13.5%) |
| Sept 2006 | - | $21.48 M(+1.9%) | $75.02 M(-12.9%) |
| June 2006 | - | $21.09 M(+5.3%) | $86.16 M(+2.5%) |
| Mar 2006 | - | $20.03 M(+61.2%) | $84.08 M(-6.7%) |
| Dec 2005 | $90.12 M(+105.1%) | $12.43 M(-61.9%) | $90.12 M(-6.9%) |
| Sept 2005 | - | $32.62 M(+71.7%) | $96.82 M(+33.2%) |
| June 2005 | - | $19.00 M(-27.1%) | $72.68 M(+17.6%) |
| Mar 2005 | - | $26.07 M(+36.3%) | $61.82 M(+40.7%) |
| Dec 2004 | $43.93 M(+41.2%) | $19.13 M(+125.5%) | $43.93 M(+30.6%) |
| Sept 2004 | - | $8.48 M(+4.2%) | $33.64 M(+2.5%) |
| June 2004 | - | $8.14 M(-0.5%) | $32.81 M(+2.1%) |
| Mar 2004 | - | $8.18 M(-7.5%) | $32.12 M(+3.2%) |
| Dec 2003 | $31.12 M(+21.0%) | $8.84 M(+15.5%) | $31.12 M(+6.6%) |
| Sept 2003 | - | $7.65 M(+2.7%) | $29.18 M(+2.9%) |
| June 2003 | - | $7.45 M(+3.8%) | $28.37 M(+4.7%) |
| Mar 2003 | - | $7.18 M(+4.0%) | $27.10 M(+5.3%) |
| Dec 2002 | $25.73 M(-10.0%) | $6.90 M(+0.9%) | $25.73 M(-5.0%) |
| Sept 2002 | - | $6.84 M(+10.7%) | $27.09 M(-2.3%) |
| June 2002 | - | $6.18 M(+6.4%) | $27.73 M(-2.7%) |
| Mar 2002 | - | $5.81 M(-29.7%) | $28.49 M(-0.3%) |
| Dec 2001 | $28.58 M(+51.4%) | $8.26 M(+10.4%) | $28.58 M(+13.7%) |
| Sept 2001 | - | $7.48 M(+7.7%) | $25.13 M(+12.5%) |
| June 2001 | - | $6.95 M(+17.9%) | $22.33 M(+30.2%) |
| Mar 2001 | - | $5.89 M(+22.4%) | $17.15 M(-9.1%) |
| Dec 2000 | $18.87 M(+20.6%) | $4.81 M(+2.9%) | $18.87 M(+34.2%) |
| Sept 2000 | - | $4.68 M(+164.4%) | $14.06 M(+49.9%) |
| June 2000 | - | $1.77 M(-76.7%) | $9.38 M(+23.3%) |
| Mar 2000 | - | $7.61 M | $7.61 M |
| Dec 1999 | $15.64 M(+43.6%) | - | - |
| Dec 1998 | $10.89 M | - | - |
FAQ
- What is Charles River Laboratories International annual depreciation & amortization?
- What is the all time high annual D&A for Charles River Laboratories International?
- What is Charles River Laboratories International annual D&A year-on-year change?
- What is Charles River Laboratories International quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly D&A year-on-year change?
- What is Charles River Laboratories International TTM depreciation & amortization?
- What is the all time high TTM D&A for Charles River Laboratories International?
- What is Charles River Laboratories International TTM D&A year-on-year change?
What is Charles River Laboratories International annual depreciation & amortization?
The current annual D&A of CRL is $314.12 M
What is the all time high annual D&A for Charles River Laboratories International?
Charles River Laboratories International all-time high annual depreciation & amortization is $314.12 M
What is Charles River Laboratories International annual D&A year-on-year change?
Over the past year, CRL annual depreciation & amortization has changed by +$10.25 M (+3.37%)
What is Charles River Laboratories International quarterly depreciation & amortization?
The current quarterly D&A of CRL is $88.20 M
What is the all time high quarterly D&A for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly depreciation & amortization is $88.20 M
What is Charles River Laboratories International quarterly D&A year-on-year change?
Over the past year, CRL quarterly depreciation & amortization has changed by +$7.68 M (+9.54%)
What is Charles River Laboratories International TTM depreciation & amortization?
The current TTM D&A of CRL is $340.15 M
What is the all time high TTM D&A for Charles River Laboratories International?
Charles River Laboratories International all-time high TTM depreciation & amortization is $340.15 M
What is Charles River Laboratories International TTM D&A year-on-year change?
Over the past year, CRL TTM depreciation & amortization has changed by +$26.03 M (+8.29%)